Deliver Your News to the World

CybeRelease: $2.25 Million Funding Received by (OTC: BSLM)


(CybeRelease, May 2, 2006) - Lake Harmony, PA - Bio-Solutions Manufacturing, Inc. (OTC BB: BSLM) (Frankfurt: B2T.F) announces the finalized agreement for straight equity financing with T & T Capital of Switzerland. The financing was done at $.50 per share with warrants at $1.00 per share. “T & T Capitol has financed many companies in the US and Europe and is looking forward to working with Bio-Solutions Manufacturing, a revolutionary bioremediation and bio-diesel company,” says Mr. Ivano Anglestri, T & T Capital’s President.

“We are very pleased to have T & T Capital as a business partner and we are looking forward to the opportunities this venture will bring,” says Mr. David Bennett, President and CEO of Bio-Solutions Manufacturing. “This funding gives us the ability to develop and market our biodiesel and environmental products. In addition, the financing will allow BSLM to join with the marketing arm of Bio-Solutions Franchise Corp. (BSFC), the corporation that has the patented grease extractor technology which allows us to produce bio-diesel.”

For in-depth analyst coverage, go to

CybeRelease Gainers are Standard Management Corporation (Nasdaq: SMAN), National Coal Corporation (Nasdaq: NCOC), MGP Ingredients, Inc. (Nasdaq: MGPI), SEI Investments Company (Nasdaq: SEIC), Altair Nanotechnologies Inc. (Nasdaq: ALTI), Gulfport Energy Corporation (Nasdaq: GPOR), LoJack Corporation (Nasdaq: LOJN) and Transmeta Corporation (Nasdaq: TMTA).

CybeRelease Decliners are deCODE genetics, Inc. (Nasdaq: DCGN), North American Scientific, Inc. (Nasdaq: NASI), ev3 Inc. (Nasdaq: EVVV), Leading Brands Inc. (Nasdaq: LBIX), United Therapeutics Corporation (Nasdaq: UTHR), Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), Unity Bancorp, Inc. (Nasdaq: UNTY) and Polydex Pharmaceuticals Limited (Nasdaq: POLXF).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $595.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.